Schedule of Condensed Balance Sheets |
Condensed Balance Sheets
| |
As
of December 31, | |
| |
2022 | | |
2023 | | |
2024 | |
| |
RMB | | |
RMB | | |
RMB | |
ASSETS | |
| | |
| | |
| |
Investment in subsidiaries | |
| 13,918 | | |
| 57,553 | | |
| 65,097 | |
Total assets | |
| 13,918 | | |
| 57,553 | | |
| 65,097 | |
| |
| | | |
| | | |
| | |
LIABILITIES | |
| | | |
| | | |
| | |
Investment deficit in subsidiaries | |
| - | | |
| - | | |
| - | |
Total liabilities | |
| - | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | |
Shareholders’ equity | |
| | | |
| | | |
| | |
Class A ordinary shares (par value of US$0.000025 per share; 80,000,000 Class A ordinary shares authorized, 21,791,187 and 22,500,000 Class A ordinary shares issued and outstanding as of December 31, 2023 and 2024, respectively)* | |
| 4 | | |
| 4 | | |
| 4 | |
Class B ordinary shares (par value of US$0.000025 per share; 1,920,000,000 Class B ordinary shares authorized, 123,354,611 and 127,500,000 Class B ordinary shares issued and outstanding as of December 31, 2023 and 2024, respectively)* | |
| 21 | | |
| 22 | | |
| 23 | |
Additional paid-in capital | |
| 168,162 | | |
| 218,284 | | |
| 220,285 | |
Accumulated deficit | |
| (154,269 | ) | |
| (160,757 | ) | |
| (155,215 | ) |
Total shareholders’
equity | |
| 13,918 | | |
| 57,553 | | |
| 65,097 | |
TOTAL LIABILITIES AND
SHAREHOLDERS’ EQUITY | |
| 13,918 | | |
| 57,553 | | |
| 65,097 | |
* | Ordinary shares and shares data are presented on a retroactive basis to reflect the reorganization (Note 1(b)) and the Share Subdivision and the Share Surrender implemented on July 15, 2024 (Note 13). |
|
Schedule of Condensed Statements of Operations and Comprehensive Income |
Condensed Statements of operations and
comprehensive income
| |
For the years ended December
31, | |
| |
2022 | | |
2023 | | |
2024 | |
| |
RMB | | |
RMB | | |
RMB | |
Operating (loss) income: | |
| | |
| | |
| |
Equity in loss of subsidiaries | |
| (13,645 | ) | |
| (6,209 | ) | |
| 5,542 | |
Loss before income tax expense | |
| (13,645 | ) | |
| (6,209 | ) | |
| 5,542 | |
Income tax expense | |
| - | | |
| - | | |
| - | |
Net (loss) income | |
| (13,645 | ) | |
| (6,209 | ) | |
| 5,542 | |
|
Schedule of Condensed Statements of Cash Flows |
Condensed Statements of Cash Flows
| |
For the years ended December
31, | |
| |
2022 | | |
2023 | | |
2024 | |
| |
RMB | | |
RMB | | |
RMB | |
Cash flows from operating activities: | |
| | | |
| | | |
| | |
Net (loss) income | |
| (13,645 | ) | |
| (6,209 | ) | |
| 5,542 | |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |
| | | |
| | | |
| | |
Equity in loss (profit) of subsidiaries | |
| 13,645 | | |
| 6,209 | | |
| (5,542 | ) |
Net cash provided by operating activities | |
| - | | |
| - | | |
| - | |
Net cash provided by investing activities | |
| - | | |
| - | | |
| | |
Net cash provided by financing activities | |
| - | | |
| - | | |
| - | |
Net increase in cash and cash equivalents | |
| - | | |
| - | | |
| - | |
Cash and cash equivalents at beginning of year | |
| - | | |
| - | | |
| - | |
Cash and cash equivalents at end of year | |
| - | | |
| - | | |
| - | |
|